SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (951)2/13/1998 1:12:00 AM
From: BulbaMan  Respond to of 3580
 
The idea would be to block cancer cells' use of telomerase to extend their telomeres. Thus, the cells would be "mortalized," and with a limited number of replications they'd be far less dangerous.
I don't know exactly what inhibitory approaches Geron and their partner, Pharmacia Upjohn, are working on to block telomerase, but my guess is they will announce a lead compound by mid-year.
For more info, I suggest you call Geron and ask to speak to one of their scientists.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News